Hanny Al-Samkari, MD

Assistant Professor of Medicine
Harvard Medical School

Hanny Al-Samkari, M.D. is an Assistant Professor of Medicine at Harvard Medical School and clinical investigator in the Massachusetts General Hospital (MGH) Division of Hematology Oncology. He also serves as Co-Director the MGH Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence. His clinical and research interests are in hemostasis and hemolysis, with focuses in HHT, anti-angiogenic therapeutics, immune thrombocytopenia, and hemolytic anemias. He is deeply involved in the development of novel therapeutics in these areas, designing and serving as PI for many clinical trials.

Presentation(s):

• SSC 03.08 - Immune Thrombocytopenic Purpura (ITP) and SARS CoV2 (COVID-19) Vaccination

  Saturday, July 9, 2022
  3:50 PM – 4:10 PM

• OC 61.1 - Risk factors for bleeding after recent medical hospitalization: The Medical Inpatient Thrombosis and Hemostasis Study (MITH)

  Tuesday, July 12, 2022
  2:45 PM – 3:00 PM

• PB0994 - Validation of the IMPROVE Hospital-Acquired Bleeding Risk Assessment Model in The Medical Inpatients Thrombosis and Hemostasis Study (MITH) Population

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1194 - Platelet Response to Avatrombopag Following Switch from Eltrombopag or Romiplostim in Primary vs. Secondary Immune Thrombocytopenia: A Multicenter Study of U.S. ITP Referral Centers

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM